Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotype - Summary - MDSpire

Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotype

  • By

  • Alexandru Mihai Dumitrescu

  • M. Frances Vest

  • Annette E. Fleckenstein

  • James C. Patterson

  • Christina Ledbetter

  • Nicholas E. Goeders

  • Jennifer M. Loftis

  • Elliot Thompson

  • Katelyn Lofton

  • Kevin S. Murnane

  • March 23, 2026

  • 0 min

Share

Objective:

To examine whether recently abstinent individuals with methamphetamine use disorder (MUD) exhibit cognitive inflexibility resembling Parkinsonian-like symptoms and how these deficits vary by sex or patterns of use.

Key Findings:
  • Both sexes in the methamphetamine group exhibited significant TMT deficits compared to controls, aligning with findings in PD populations.
  • Age of first use, duration, and amount of methamphetamine used did not significantly affect cognitive performance.
  • Intravenous use was associated with a higher number of TMT errors in females, indicating a potential sex difference in cognitive impact.
Interpretation:

These findings suggest that methamphetamine use may induce cognitive deficits resembling an early Parkinsonian-like phenotype, particularly highlighting the increased risk for women who inject methamphetamine.

Limitations:
  • The small sample size may limit the generalizability of the findings.
  • The cross-sectional design does not allow for causal inferences regarding the relationship between methamphetamine use and cognitive deficits.
Conclusion:

Cognitive inflexibility in individuals with MUD may impede treatment engagement, underscoring the necessity for comprehensive interventions that specifically address these cognitive deficits.

Original Source(s)

Related Content